Documents
Lisinopril Assay and Related Substances Method per IP Monograph
In this application note, we report the separation of Lisinopril and its related substances using a Luna™ 5 μm C8(2) column and a Kinetex™ 5 μm C8 column according to the Indian Pharmacopoeia (IP) Monograph for Lisinopril. While the data demonstrates that the use of either column would be acceptable, the core-shell Kinetex C8 column provided shorter run times, while the Luna C8(2) column provided slightly better peak shape.
Lisinopril Assay and Related Substances Method per IP Monograph
In this application note, we report the separation of Lisinopril and its related substances using a Luna™ 5 μm C8(2) column and a Kinetex™ 5 μm C8 column according to the Indian Pharmacopoeia (IP) Monograph for Lisinopril. While the data demonstrates that the use of either column would be acceptable, the core-shell Kinetex C8 column provided shorter run times, while the Luna C8(2) column provided slightly better peak shape.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Phases:
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
